drugset / Trial / NCT03844451

Enhanced Recovery With Liposomal Bupivacaine in Orthognathic Surgery

NCT03844451 ↗

Phase 4 Unknown 75 enrolled University of Texas at Austin
RandomizedParallel-groupOpen-labelTreatment

Summary

The proposed study design is a prospective, clinical trial comparing control group patients (CG; ncg = 30) that will undergo conventional perioperative management without an ERAS protocol and standard bupivacaine intraoperative nerve block to randomized treatment group patients that will receive an intraoperative V2 trigeminal nerve block using LB (TG; ntg = 30).

Timeline

Start
2019-05-17
Primary completion
2019-09-01
Completion
2019-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Background Epinephrine Other / unclassified — Other

Indications